Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):1. doi: 10.1038/mp.2012.177. No abstract available.

PMID:
23250327
2.

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):93-100. doi: 10.1038/mp.2012.93. Epub 2012 Jul 3.

3.

Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635.

Saijo T, Takano A, Suhara T, Arakawa R, Okumura M, Ichimiya T, Ito H, Okubo Y.

Int J Neuropsychopharmacol. 2010 Jul;13(6):785-91. doi: 10.1017/S1461145709991209. Epub 2010 Jan 13.

PMID:
20067660
4.

Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635.

Hahn A, Nics L, Baldinger P, Wadsak W, Savli M, Kraus C, Birkfellner W, Ungersboeck J, Haeusler D, Mitterhauser M, Karanikas G, Kasper S, Frey R, Lanzenberger R.

Nucl Med Biol. 2013 Apr;40(3):371-7. doi: 10.1016/j.nucmedbio.2012.12.011. Epub 2013 Jan 30.

PMID:
23375480
5.

The 5-HT1A receptor in Major Depressive Disorder.

Kaufman J, DeLorenzo C, Choudhury S, Parsey RV.

Eur Neuropsychopharmacol. 2016 Mar;26(3):397-410. doi: 10.1016/j.euroneuro.2015.12.039. Epub 2016 Jan 11. Review.

6.

Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.

Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV.

Biol Psychiatry. 2009 Aug 1;66(3):223-30. doi: 10.1016/j.biopsych.2009.01.028. Epub 2009 Mar 17.

7.

Complete normalization of severe brain 18F-FDG hypometabolism following electroconvulsive therapy in a major depressive episode.

Lajoie C, Levasseur MA, Paquet N.

Clin Nucl Med. 2013 Sep;38(9):735-6. doi: 10.1097/RLU.0b013e31829b9bd9.

PMID:
23816946
8.

Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder.

Gray NA, Milak MS, DeLorenzo C, Ogden RT, Huang YY, Mann JJ, Parsey RV.

Biol Psychiatry. 2013 Jul 1;74(1):26-31. doi: 10.1016/j.biopsych.2012.11.012. Epub 2013 Jan 29.

9.

Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety.

Sullivan GM, Oquendo MA, Simpson N, Van Heertum RL, Mann JJ, Parsey RV.

Biol Psychiatry. 2005 Dec 15;58(12):947-54. Epub 2005 Jul 22.

PMID:
16039621
10.

Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.

Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H, Någren K, Salminen JK, Hietala J.

Int J Neuropsychopharmacol. 2008 Jun;11(4):465-76. Epub 2007 Oct 31.

PMID:
17971260
11.

Differences in cerebral blood flow between missed and generalized seizures with electroconvulsive therapy: a positron emission tomographic study.

Takano H, Motohashi N, Uema T, Ogawa K, Ohnishi T, Nishikawa M, Matsuda H.

Epilepsy Res. 2011 Nov;97(1-2):225-8. doi: 10.1016/j.eplepsyres.2011.08.007. Epub 2011 Sep 13.

PMID:
21917425
12.

Electroconvulsive therapy decreases dopamine D₂receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [¹¹C]FLB 457.

Saijo T, Takano A, Suhara T, Arakawa R, Okumura M, Ichimiya T, Ito H, Okubo Y.

J Clin Psychiatry. 2010 Jun;71(6):793-9. doi: 10.4088/JCP.08m04746blu. Epub 2009 Dec 15.

PMID:
20021995
13.

[Electroconvulsive therapy in depression: insights from fMRI, PET and SPECT studies].

Depping MS, Wolf RC, Nolte HM, Palm E, Hirjak D, Thomann PA.

Fortschr Neurol Psychiatr. 2014 Sep;82(9):511-22. doi: 10.1055/s-0034-1384892. Epub 2014 Sep 1. Review. German.

PMID:
25177903
14.

5-HT(1A) receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: a pilot [¹⁸F]MPPF positron emission tomography study.

Lothe A, Saoud M, Bouvard S, Redouté J, Lerond J, Ryvlin P.

Psychiatry Res. 2012 Jul 30;203(1):103-4. doi: 10.1016/j.pscychresns.2011.09.001. Epub 2012 Aug 3.

PMID:
22863653
15.

Reduced serotonin type 1A receptor binding in panic disorder.

Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets WC.

J Neurosci. 2004 Jan 21;24(3):589-91.

16.

Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.

Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge J, Ziolko SK, McConaha CW, Kaye WH.

Arch Gen Psychiatry. 2005 Sep;62(9):1032-41.

PMID:
16143735
17.

No association between serotonin 5-HT 1A receptors and spirituality among patients with major depressive disorders or healthy volunteers.

Karlsson H, Hirvonen J, Salminen JK, Hietala J.

Mol Psychiatry. 2011 Mar;16(3):282-5. doi: 10.1038/mp.2009.126. Epub 2009 Nov 24. Erratum in: Mol Psychiatry. 2012 Apr;17(4):467.

PMID:
19935737
18.

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.

Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ.

Mol Psychiatry. 2004 Apr;9(4):386-92.

PMID:
15042104
19.

In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography.

Comley RA, van der Aart J, Gulyás B, Garnier M, Iavarone L, Halldin C, Rabiner EA.

Neuropharmacology. 2015 May;92:44-8. doi: 10.1016/j.neuropharm.2014.11.017. Epub 2014 Dec 2.

PMID:
25476970
20.

Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.

Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ.

Biol Psychiatry. 2006 Jan 15;59(2):106-13. Epub 2005 Sep 9.

PMID:
16154547

Supplemental Content

Support Center